C14ORF21 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.899600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.857000E-01
Normal-vs-Stage2
9.599000E-01
Normal-vs-Stage3
2.261600E-01
Normal-vs-Stage4
8.587600E-01
Stage1-vs-Stage2
8.010000E-01
Stage1-vs-Stage3
2.869600E-02
Stage1-vs-Stage4
8.669600E-01
Stage2-vs-Stage3
6.039600E-02
Stage2-vs-Stage4
7.009800E-01
Stage3-vs-Stage4
1.637240E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.644400E-01
Normal-vs-AfricanAmerican
7.691400E-01
Normal-vs-Asian
7.226200E-01
Caucasian-vs-AfricanAmerican
4.297600E-01
Caucasian-vs-Asian
5.844400E-01
AfricanAmerican-vs-Asian
3.925400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.293800E-01
Normal-vs-Female
8.490400E-01
Male-vs-Female
6.837800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.702600E-01
Normal-vs-Age(41-60Yrs)
9.001800E-01
Normal-vs-Age(61-80Yrs)
7.653200E-01
Normal-vs-Age(81-100Yrs)
9.584200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.338000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.177600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.139800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.318760E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.304600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.513800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.946800E-01
Normal-vs-Daily Drinker
4.821200E-01
Normal-vs-Weekly Drinker
8.031000E-01
Normal-vs-Occasional Drinker
9.518800E-01
Normal-vs-Social Drinker
5.754200E-01
Non Drinker-vs-Daily Drinker
2.638600E-01
Non Drinker-vs-Weekly Drinker
7.545600E-01
Non Drinker-vs-Occasional Drinker
8.457200E-01
Non Drinker-vs-Social Drinker
2.042000E-01
Daily Drinker-vs-Weekly Drinker
5.807600E-01
Daily Drinker-vs-Occasional Drinker
1.667400E-01
Daily Drinker-vs-Social Drinker
1.943920E-02
Weekly Drinker-vs-Occasional Drinker
6.586200E-01
Weekly Drinker-vs-Social Drinker
2.019200E-01
Occasional Drinker-vs-Social Drinker
2.158000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.496200E-01
Normal-vs-Grade 2
1.737170E-01
Normal-vs-Grade 3
4.730200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.028800E-01
Grade 1-vs-Grade 3
3.384200E-02
Grade 1-vs-Grade 4
3.496200E-01
Grade 2-vs-Grade 3
9.059600E-03
Grade 2-vs-Grade 4
1.737170E-01
Grade 3-vs-Grade 4
4.730200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.467200E-01
Normal-vs-NonDiabetic
7.884200E-01
Diabetic-vs-NonDiabetic
8.135400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.325400E-01
Normal-vs-NoPancreatitis
7.896600E-01
Pancreatitis-vs-NoPancreatitis
4.681400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.202600E-01
Normal-vs-N1
9.365000E-01
N0-vs-N1
5.595000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.618600E-01
Normal-vs-TP53-NonMutant
9.232600E-01
TP53-Mutant-vs-TP53-NonMutant
5.286600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
